Works matching IS 02698811 AND DT 2023 AND VI 37 AND IP 10
Results: 11
Clinical quandaries in psychotic disorders: the road is long, with many a winding turn.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 951, doi. 10.1177/02698811231206445
- By:
- Publication type:
- Article
Second International Consensus Study of Antipsychotic Dosing (ICSAD-2).
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 982, doi. 10.1177/02698811231205688
- By:
- Publication type:
- Article
Comparative efficacy of quetiapine by dose and formulation for psychosis in schizophrenia: A systematic review and dose–response model-based network meta-analysis.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 953, doi. 10.1177/02698811231200020
- By:
- Publication type:
- Article
Predicting clozapine dose required to achieve a therapeutic plasma concentration – A comparison of a population algorithm and three algorithms based on gene variant models.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 1030, doi. 10.1177/02698811231199104
- By:
- Publication type:
- Article
Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 1040, doi. 10.1177/02698811231191781
- By:
- Publication type:
- Article
QTc prolongation in patients with schizophrenia taking antipsychotics: Prevalence and risk factors.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 971, doi. 10.1177/02698811231190864
- By:
- Publication type:
- Article
Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 1003, doi. 10.1177/02698811231186760
- By:
- Publication type:
- Article
Postpartum psychosis: A proposed treatment algorithm.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 960, doi. 10.1177/02698811231181573
- By:
- Publication type:
- Article
Body mass index, waist circumference, insulin, and leptin plasma levels differentiate between clozapine-responsive and clozapine-resistant schizophrenia.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 1023, doi. 10.1177/02698811231181565
- By:
- Publication type:
- Article
The histamine system and cognitive function: An in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 1011, doi. 10.1177/02698811231177287
- By:
- Publication type:
- Article
Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice.
- Published in:
- Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 992, doi. 10.1177/02698811231177268
- By:
- Publication type:
- Article